[1] |
Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: advances in the 21st century[J]. Clin Microbiol Rev, 2019, 32(2): 1-2.
|
[2] |
Siles-Lucas M, Casulli A, Cirilli R, et al. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets[J]. PLoS Negl Trop Dis, 2018, 12(4): e0006422.
doi: 10.1371/journal.pntd.0006422
|
[3] |
Stojkovic M, Mickan C, Weber TF, et al. Pitfalls in diagnosis and treatment of alveolar echinococcosis: a sentinel case series[J]. BMJ Open Gastroenterol, 2015, 2(1): e000036.
doi: 10.1136/bmjgast-2015-000036
|
[4] |
Spiliotis M, Lechner S, Tappe D, et al. Transient transfection of Echinococcus multilocularis primary cells and complete in vitro regeneration of metacestode vesicles[J]. Int J Parasitol, 2008, 38(8/9): 1025-1039.
doi: 10.1016/j.ijpara.2007.11.002
|
[5] |
Spiliotis M, Brehm K. Axenic in vitro cultivation of Echinococcus multilocularis metacestode vesicles and the generation of primary cell cultures[J]. Methods Mol Biol, 2009, 470(1): 245-262.
|
[6] |
Flory J, Lipska K. Metformin in 2019[J]. JAMA, 2019, 321(19): 1926-1927.
doi: 10.1001/jama.2019.3805
|
[7] |
Harati R, Vandamme M, Blanchet B, et al. Drug-drug interaction between metformin and sorafenib alters antitumor effect in hepatocellular carcinoma cells[J]. Mol Pharmacol, 2021, 100(1): 32-45.
doi: 10.1124/molpharm.120.000223
pmid: 33990407
|
[8] |
Ashrafizadeh M, Mirzaei S, Hushmandi K, et al. Therapeutic potential of AMPK signaling targeting in lung cancer: advances, challenges and future prospects[J]. Life Sci, 2021, 278: 119649.
doi: 10.1016/j.lfs.2021.119649
pmid: 34043989
|
[9] |
Koroglu-Aydn P, Bayrak BB, Bugan I, et al. Histological and biochemical investigation of the renoprotective effects of metformin in diabetic and prostate cancer model[J]. Toxicol Mech Methods, 2021, 31(7): 489-500.
doi: 10.1080/15376516.2021.1919810
|
[10] |
Alhourani AH, Tidwell TR, Bokil AA, et al. Metformin treatment response is dependent on glucose growth conditions and metabolic phenotype in colorectal cancer cells[J]. Sci Rep, 2021, 11(1): 1-10.
doi: 10.1038/s41598-020-79139-8
|
[11] |
Wang Z, Guo JJ, Han XQ, et al. Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE(-/-) mice[J]. Cell Biosci, 2019, 9(1): 1-15.
doi: 10.1186/s13578-018-0263-x
|
[12] |
Guo LM, Cui J, Wang HR, et al. Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways[J]. Mol Ther Oncolytics, 2021, 20: 119-131.
doi: 10.1016/j.omto.2020.11.004
|
[13] |
Ouyang JY, Parakhia RA, Ochs RS. Metformin activates AMP kinase through inhibition of AMP deaminase[J]. J Biol Chem, 2011, 286(1): 1-11.
doi: 10.1074/jbc.M110.121806
|
[14] |
Zheng LY, Yang W, Wu FQ, et al. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma[J]. Clin Cancer Res, 2013, 19(19): 5372-5380.
doi: 10.1158/1078-0432.CCR-13-0203
|
[15] |
Loos JA, Dávila VA, Brehm K, et al. Metformin suppresses development of the Echinococcus multilocularis larval stage by targeting the TOR pathway[J]. Antimicrob Agents Chemother, 2020, 64(9): e01808-e01827.
|
[16] |
Brehm K, Wolf M, Beland H, et al. Analysis of differential gene expression in Echinococcus multilocularis larval stages by means of spliced leader differential display[J]. Int J Parasitol, 2003, 33(11): 1145-1159.
doi: 10.1016/S0020-7519(03)00169-3
|
[17] |
Hemer S, Brehm K. In vitro efficacy of the anticancer drug imatinib on Echinococcus multilocularis larvae[J]. Int J Antimicrob Agents, 2012, 40(5): 458-462.
doi: 10.1016/j.ijantimicag.2012.07.007
|
[18] |
Stadelmann B, Aeschbacher D, Huber C, et al. Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodes[J]. PLoS Negl Trop Dis, 2014, 8(12): e3352.
doi: 10.1371/journal.pntd.0003352
|
[19] |
Cheng Z, Xu Z, Tian H, et al. In vitro and efficacies of inhibitors of the EGFR/MEK/ERK signaling in the treatment of alveolar echinococcosis[J]. Antimicro Agents Chemo, 2020, 64(8): 234-236.
|
[20] |
Saraei P, Asadi I, Kakar MA, et al. The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances[J]. Cancer Manag Res, 2019, 11: 3295-3313.
doi: 10.2147/CMAR.S200059
pmid: 31114366
|
[21] |
Sanli T, Steinberg GR, Singh G, et al. AMP-activated protein kinase (AMPK) beyond metabolism[J]. Cancer Biol Ther, 2014, 15(2): 156-169.
doi: 10.4161/cbt.26726
|
[22] |
Jia JY, Bissa B, Brecht L, et al. AMPK, a regulator of metabolism and autophagy, is activated by lysosomal damage via a novel galectin-directed ubiquitin signal transduction system[J]. Mol Cell, 2020, 77(5): 951-969.
doi: 10.1016/j.molcel.2019.12.028
|
[23] |
Zaidi S, Gandhi J, Joshi G, et al. The anticancer potential of metformin on prostate cancer[J]. Prostate Cancer Prostatic Dis, 2019, 22(3): 351-361.
doi: 10.1038/s41391-018-0085-2
|
[24] |
Fan H, Yu X, Zou Z, et al. Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway[J]. Carcinogenesis, 2019, 40(5): 669-679.
doi: 10.1093/carcin/bgy160
|
[25] |
Lee J, Hong EM, Kim JH, et al. Metformin induces apoptosis and inhibits proliferation through the AMP-activated protein kinase and insulin-like growth factor 1 receptor pathways in the bile duct cancer cells[J]. J Cancer, 2019, 10(7): 1734-1744.
doi: 10.7150/jca.26380
|
[26] |
Guillermo M, Mireia NS, Eric HB, et al. Self-consumption: the interplay of autophagy and apoptosis[J]. Nat Rev Mol Cell Biol, 2014, 15(2): 81-90.
doi: 10.1038/nrm3735
|
[27] |
Wang Y, Zhang YF, Feng XM, et al. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells[J]. Oncol Rep, 2021, 45(3): 1249-1260.
doi: 10.3892/or
|
[28] |
Yang HC, Zhang HW, Shi KJ, et al. Autocrine osteopontin promotes the growth and metastasis of Echinococcus multilocu-laris via the EGFR signaling pathway[J]. Chin J Parasitol Parasit Dis, 2021, 39(2): 226-232. (in Chinese)
|
|
(杨海成, 张宏伟, 史康杰, 等. 自分泌骨桥蛋白通过EGFR信号通路促进多房棘球蚴生长和转移的研究[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(2): 226-232.)
|
[29] |
Tan XW, Yu XF, Jiang HQ, et al. Inhibitory effect of xanthohumol on the growth of Echinococcus multilocularis[J]. Chin J Parasitol Parasit Dis, 2021, 39(3): 304-310. (in Chinese)
|
|
(谭小武, 俞晓凡, 姜慧娇, 等. 黄腐酚对小鼠肝多房棘球蚴生长的抑制作用[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(3): 304-310.)
|